Humana slumps due to Medicaid costs

By Admin
Written by Alyssa Clark Humana is known throughout the country as one of the U.S.s leading health insurance providers, holding a firm position in the...

Written by Alyssa Clark


Humana is known throughout the country as one of the U.S.’s leading health insurance providers, holding a firm position in the insurance market for the past 10 years. This past Wednesday, representatives from Humana said they are expected a substantial decline in earnings this next year due to health exchanges and the Medicaid program which caters to the U.S.’s poor.

Underneath the national healthcare reform law, Humana and other insurance providers began administering insurance plans to people on October 1st. These state-based exchanges will become active in 2014. Humana has also overseen care contracts with a few states, in terms of managing their Medicaid health plans.

Humana projects its price per share earnings in 2014 to be around $7.25 to $7.75, which is adding in the 50-90 cents for Medicaid and health exchange costs.

"Although we expect shares to react negatively to the guidance, we find the outlook somewhat reassuring as it implies general stability in core operations/margins offset by semi-discretionary and transient upfront investment spending," Susquehanna Financial Group analyst Chris Rigg said in a research note.

In the year of 2013, Humana is still projecting earnings of $8.65 to $8.75 per share, which makes the substantial $1.40 drop stand out even more.

“Analysts on average were expecting a profit of $8.69 per share for the year”, according to Thomson Reuters I/B/E/S.

“It was not immediately clear if that consensus figure included any spending on those investments”.

Humana’s forecast for 2014 still aligns with analysts’ estimations, projecting the company to still gross $43 billion for the upcoming year.

“Third-quarter net income at Humana fell to $368 million, or $2.31 per share, from $426 million, or $2.62 per share, a year earlier. The results beat analysts' expectations of $2.15 per share. Revenue rose 7 percent to $10.32 billion from $9.65 billion a year earlier, but the company paid out more in claims and had higher operating costs”, according to Thomson Reuters.


About the Author

Alyssa Clark is the Editor of Healthcare Global


Featured Articles

Digital healthcare platform Balanced supports healthy ageing

10,000 people turn 65 in the USA each day. Digital healthcare platform Balanced wants to help them better manage healthy ageing, says CEO Katie Reed

TrueBinding’s antibody drugs fight Alzheimer’s Disease

Dongxu Sun, CEO at TrueBinding, shares how its research & antibody drug development is fighting illnesses such as Alzheimer’s Disease, stroke & more

Cardinal Health’s clinically integrated pharma supply chain

Peter J. Siavelis, SVP & General Manager, Health System & Provider Distribution & Services at Cardinal Health, discusses the integrated pharma supply chain

Healthcare Digital news roundup: digital healthcare & AI

Digital Healthcare

Hospitals must embrace IoMT device security


Mental health support for working women and mothers

Digital Healthcare